Get early access! Join the Twelve Data AI Assistant waitlist now.

HALO

65.13000 USD
1.09
1.70%
Last update Aug 13, 3:59 PM EDT
Market closed
Day range
63.64000
65.15000
Previous close
64.040001
Open
64.69000
Access this stock data via API
Subscribe
Halozyme Therapeutics Inc.
65.13
1.09
1.70%

Financials

Income statement

Fiscal date Jun 2025 Mar 2025 Dec 2024 Sep 2024
Total reported revenue 325.7M 264.9M 298.0M 290.1M
Cost of revenue 46.4M 48.4M 42.1M 49.4M
Gross profit 279.4M 216.5M 256.0M 240.7M
Operating expense
Research & development 17.5M 14.8M 20.4M 18.5M
Selling general and admin 41.6M 42.4M 42.2M 41.2M
Other operating expenses
Operating income 202.4M 141.5M 175.5M 163.2M
Non operating interest income
Income
Expense 4.4M 4.5M 4.5M 4.5M
Other income expense 6.9M 6.8M 7.3M 6.5M
Pretax income 204.9M 143.8M 178.2M 165.1M
Tax provision 39.8M 25.7M 41.2M 28.1M
Net income 165.2M 118.1M 137.0M 137.0M
Basic EPS 1.4 1.0 1.1 1.1
Diluted EPS 1.3 0.9 1.1 1.1
Basic average shares 121.3M 123.2M 126.4M 126.9M
Diluted average shares 124.2M 126.6M 129.0M 130.1M
EBITDA 222.9M 162.0M 195.9M 183.6M
Net income from continuing op. 165.2M 118.1M 137.0M 137.0M
Minority interests
Preferred stock dividends
Market closed

Exchange is currently closed
Pre-market opens in 4 hours 49 minutes

23:10
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EDT, UTC-04:00).